The synthetic hepatic peptides pyroglutamylglutamylglycylserylasparagine and pyroglutamylglutamylglycylserylaspartic acid inhibit growth of MH1C1 rat hepatoma cells transplanted into Buffalo rats or athymic mice.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Cancer Research

• Publication date

  1992-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 1310641
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatic proliferation inhibitor

  2004cited by this paper
• Mouse liver regeneration after carbon tetrachloride injury as test system for hepatic growth regulators

  1992cited by this paper
• Tumor suppressor genes.

  1991cited by this paper
• Growth factors in development, transformation, and tumorigenesis.

  1991cited by this paper
• Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation.

  1991cited by this paper
• The peptide pyroGlu-Gln-Gly-Ser-Asn, isolated from mouse liver, inhibits growth of rat hepatoma cells in vitro.

  1991cited by this paper
• Cooperation between oncogenes.

  1991cited by this paper
• TGF-p Stimulation and Inhibition of Cell Proliferation: New Mechanistic Insights Minireview

  1990cited by this paper
• Liver regeneration: molecular mechanisms of growth control

  1990cited by this paper
• Isolation of a growth and mitosis inhibitory peptide from mouse liver

  1990cited by this paper
• TGF-beta stimulation and inhibition of cell proliferation: new mechanistic insights.

  1990cited by this paper
• Pentapeptide Growth Inhibitors

  1990cited by this paper
• TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights

  1990cited by this paper
• Growth inhibitors: Molecular diversity and roles in cell proliferation

  1989cited by this paper
• Growth modulatory effects of a liver-derived growth inhibitor, transforming growth factor beta 1, and recombinant tumor necrosis factor alpha, in normal and neoplastic cells.

  1989cited by this paper
• Growth modulatory effects of a liver-derived growth inhibitor, transforming growth factor β1, and recombinant tumor necrosis factor α, in normal and neoplastic cells

  1989cited by this paper
• An endogenous colon mitosis inhibitor reduces proliferation of colon carcinoma cells (HT 29) in serum-restricted medium

  1988cited by this paper
• Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat.

  1988cited by this paper
• Regulatory effects of cell density on the binding of transforming growth factor beta, epidermal growth factor, platelet-derived growth factor, and fibroblast growth factor.

  1988cited by this paper
• In vitro growth inhibition of human small cell lung cancer by physalaemin.

  1987cited by this paper
• The regulation of cyclic AMP levels in cultured MH1C1 rat hepatoma cells and in solid tumours derived from MH1C1 cell inoculates.

  1987cited by this paper
• Purification and characterization of a growth inhibitory hepatic peptide

  1987cited by this paper
• [Cooperation between oncogenes: the function of immortalizing oncogenes].

  1986cited by this paper
• Purified epidermal pentapeptide inhibits proliferation and enhances terminal differentiation in cultured mouse epidermal cells.

  1986cited by this paper
• Purification and characterization of a mitosis inhibiting epidermal peptide.

  1984cited by this paper
• Isolation and Synthesis of a Hemoregulatory Peptide

  1982cited by this paper

• Biochemical requirements of bioactive peptides for nutraceutical efficacy

  2018cites this paper
• Low MW Peptides and Carcinogenesis

  2015cites this paper
• A comparative analysis of radiometric and autoradiographic methods for studies of DNA-synthesizing activities of cellsin vitro

  2006cites this paper
• Chalones – From Aqueous Extracts To Oligopeptides

  2004cites this paper
• Peptides with anticancer use or potential

  2003cites this paper
• Endogenous tetrapeptide from neuroblastoma and new-born pig brain inhibits neuroblastoma cell growth in vitro.

  2002cites this paper
• Small acidic peptides and peptidomimetic molecules: cell growth and differentiation.

  2000cites this paper
• Novel lymphocyte growth-inhibiting tripeptide: N-acetyl-glu-ser-GlyNH(2).

  2000cites this paper
• Molecular Models of Acidic PePtides From Pea Bud Chromatin And Seminal Plasma. Divalent Cations-Mediated Interaction With Dna

  1999cites this paper
• Growth-inhibiting N-substituted endogenous peptides.

  1998cites this paper
• Mass spectral and electrophoretic characterization of acidic peptides bound to chromatin of Pea Bud

  1998cites this paper
• Comparative analysis of radiometric and autoradiographic methods in the investigation of DNA synthetic activity of tumor cells in vitro.

  1997cites this paper
• Difference in the distribution of low-molecular-weight peptides and amino-acids in normal and malignant-cells and tissues.

  1994cites this paper
• Liver regeneration in trypsin-fed partially hepatectomized rats.

  1993cites this paper
• The synthetic colon peptide pyroGlu-His-GlyOH inhibits growth of human colon carcinoma cells (HT-29) transplanted subcutaneously into athymic mice.

  1993cites this paper
• Modulation of KB and A431 cell adhesion by epidermal growth inhibitory pentapeptide

  1992cites this paper